Mohamed Abdallah

Mohamed Abdallah possesses extensive experience in the pharmaceutical industry, currently serving as the Methodology & Stability Director at BIOMED for Pharmaceutical Industries since February 2022. Previously held the position of Methodology & Stability Manager at the same company and contributed to Mash Premiere as a Stability-and-Methodology Manager since November 2011. Key responsibilities include preparing stability study protocols, validation SOPs for analytical test methods, reviewing and assuring instrumental calibration, and approving validation and stability files for drug registration. Additionally, Mohamed has experience as the Head of Section Stability at Mash Premiere and worked as a Bioequivalence Analyst at the Egyptian Research and Development Company from January 2007 to November 2011.